Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

• Conditions: Male Breast Cancer

• Registration Number: NCT03240510
• Lead Sponsor: Salah Azaïz Cancer Institute

Brief Summary

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years.

Goal of the retrospective part: to gather clinicopathologic data and follow-up outcomes of male breast cancer patients diagnosed and/or treated at Salah Azaïz Cancer Institute from 2004 to 2013.

Goal of the prospective part: to create a registry of male patients with breast cancer for a period of 48 months (from 2014 to 2017).

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01-01
• Primary Completion: 2016-12-31
• Study First Submitted: 2017-07-28
• Status Verified: 2017-08
• Study First Submitted QC: 2017-08-01
• Last Update Submitted: 2017-08-01
• Study First Posted: 2017-08-07
• Last Update Posted: 2017-08-07
• Study Completion: 2018-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 150

Inclusion Criteria

Histological diagnosis of male breast cancer

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinico-biological characteristics of the disease	Through study completion, an average of 4 year
Clinical outcomes	Through study completion, an average of 4 year	Survival, Disease free survival

Trial Locations

Locations (1)

Salah Azaïz Cancer Institute; 🇹🇳 Tunis, Tunisia